Clinical Trial Update: Angiogenic Switch in Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on an angiogenic switch in colorectal cancer; current status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Grupo Hospital de Madrid | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN